About us
An innovation infrastructure for ideas in the vast areas of Cannabis pharmaceuticals
who we Are
CannaMore is in a unique and advantageous position in the Cannabis pharmaceutical fields with strong and strategic partners who allow it to be an innovation infrastructure for multiple ideas in a wide range of Cannabis Drug development
Out strategic partner and shareholder
Out strategic partner and shareholder, the TTO of Clalit allows the company to enjoy:
- Close proximity to leading research
- Access to leading clinical centers
- Direct and Immediate collaboration with leading KOLs and physicians
- An insider’s look into one of Israel’s leading innovation
- IP generation centers
Clalit in a glance:
- Over 4.7 M members
- 14 full scale operating hospitals specializing in all fields of medicine
- Over 2,000 community clinics
- Over 11,000 employed physicians